Price target
19.770.000.00%
The 8 analysts offering 1 year price forecasts for 1GDA have a max estimate of — and a min estimate of —.
Analyst rating
Based on 8 analysts giving stock ratings to 1GDA in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
1GDA EPS for the last quarter is 1.03 EUR despite the estimation of 1.92 EUR. In the next quarter EPS is expected to reach −0.03 EUR. Track more of Zevra Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Zevra Therapeutics, Inc. revenue is expected to reach 22.70 M EUR. Check out Zevra Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, 1GDA price target is 19.77 EUR with a max estimate of 24.69 EUR and a min estimate of 15.32 EUR. Check if this forecast comes true in a year, meanwhile watch Zevra Therapeutics, Inc. stock price chart and keep track of the current situation with 1GDA news and stock market news.
We've gathered opinions of 8 analysts rating 1GDA stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.